![D. Osborne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
D. Osborne
Financieel Directeur/CFO bij Melt Pharmaceuticals, Inc.
Profiel
D.
Bradford Osborne is currently the Chief Financial Officer at Melt Pharmaceuticals, Inc. Prior to this, he worked at Precigen, Inc. as the Principal Accounting Officer & VP-Finance from 2011 to 2021.
Actieve functies van D. Osborne
Bedrijven | Functie | Begin |
---|---|---|
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Financieel Directeur/CFO | 01-02-2022 |
Eerdere bekende functies van D. Osborne
Bedrijven | Functie | Einde |
---|---|---|
PRECIGEN, INC. | Financieel Directeur/CFO | 10-06-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PRECIGEN, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Health Technology |